Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

USA - NYSE:ICL - IL0002810146 - Common Stock

6.59 USD
-0.25 (-3.65%)
Last: 10/14/2025, 4:15:00 PM
6.59 USD
0 (0%)
After Hours: 10/14/2025, 4:15:00 PM
Fundamental Rating

5

Taking everything into account, ICL scores 5 out of 10 in our fundamental rating. ICL was compared to 83 industry peers in the Chemicals industry. While ICL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ICL is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ICL was profitable.
In the past year ICL had a positive cash flow from operations.
Each year in the past 5 years ICL has been profitable.
Each year in the past 5 years ICL had a positive operating cash flow.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

ICL has a better Return On Assets (2.97%) than 63.86% of its industry peers.
The Return On Equity of ICL (6.10%) is better than 67.47% of its industry peers.
The Return On Invested Capital of ICL (5.24%) is better than 60.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICL is significantly above the industry average of 6.30%.
The last Return On Invested Capital (5.24%) for ICL is well below the 3 year average (13.86%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROIC 5.24%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 5.28%, ICL is in the better half of the industry, outperforming 71.08% of the companies in the same industry.
In the last couple of years the Profit Margin of ICL has declined.
The Operating Margin of ICL (10.46%) is better than 60.24% of its industry peers.
In the last couple of years the Operating Margin of ICL has declined.
Looking at the Gross Margin, with a value of 32.29%, ICL is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
ICL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ICL is creating value.
Compared to 1 year ago, ICL has about the same amount of shares outstanding.
Compared to 5 years ago, ICL has more shares outstanding
Compared to 1 year ago, ICL has an improved debt to assets ratio.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ICL has an Altman-Z score of 2.44. This is not the best score and indicates that ICL is in the grey zone with still only limited risk for bankruptcy at the moment.
ICL's Altman-Z score of 2.44 is fine compared to the rest of the industry. ICL outperforms 68.67% of its industry peers.
ICL has a debt to FCF ratio of 6.12. This is a slightly negative value and a sign of low solvency as ICL would need 6.12 years to pay back of all of its debts.
ICL has a Debt to FCF ratio of 6.12. This is in the better half of the industry: ICL outperforms 75.90% of its industry peers.
ICL has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ICL has a better Debt to Equity ratio (0.42) than 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Altman-Z 2.44
ROIC/WACC0.69
WACC7.61%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.75 indicates that ICL should not have too much problems paying its short term obligations.
ICL's Current ratio of 1.75 is on the low side compared to the rest of the industry. ICL is outperformed by 60.24% of its industry peers.
ICL has a Quick Ratio of 1.05. This is a normal value and indicates that ICL is financially healthy and should not expect problems in meeting its short term obligations.
ICL has a Quick ratio of 1.05. This is in the lower half of the industry: ICL underperforms 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.05
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

ICL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.50%.
Looking at the last year, ICL shows a decrease in Revenue. The Revenue has decreased by -1.22% in the last year.
ICL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.35% yearly.
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%

3.2 Future

The Earnings Per Share is expected to grow by 11.46% on average over the next years. This is quite good.
Based on estimates for the next years, ICL will show a small growth in Revenue. The Revenue will grow by 4.13% on average per year.
EPS Next Y-1.04%
EPS Next 2Y10.53%
EPS Next 3Y11.46%
EPS Next 5YN/A
Revenue Next Year3.8%
Revenue Next 2Y4.5%
Revenue Next 3Y4.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.81, ICL is valued on the expensive side.
ICL's Price/Earnings is on the same level as the industry average.
ICL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.34.
The Price/Forward Earnings ratio is 14.19, which indicates a correct valuation of ICL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICL is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ICL to the average of the S&P500 Index (22.86), we can say ICL is valued slightly cheaper.
Industry RankSector Rank
PE 17.81
Fwd PE 14.19
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ICL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ICL is cheaper than 67.47% of the companies in the same industry.
ICL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ICL is cheaper than 71.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.87
EV/EBITDA 8.24
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of ICL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.53%
EPS Next 3Y11.46%

3

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 2.79%. Purely for dividend investing, there may be better candidates out there.
ICL's Dividend Yield is a higher than the industry average which is at 3.69.
ICL's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

64.85% of the earnings are spent on dividend by ICL. This is not a sustainable payout ratio.
DP64.85%
EPS Next 2Y10.53%
EPS Next 3Y11.46%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (10/14/2025, 4:15:00 PM)

After market: 6.59 0 (0%)

6.59

-0.25 (-3.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners25.14%
Inst Owner Change-0.81%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap8.51B
Analysts47.5
Price Target0.02 (-99.7%)
Short Float %0.23%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP64.85%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-03 2025-09-03 (0.1442436)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.62%
Min EPS beat(2)-18.25%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)1.71%
Min EPS beat(4)-18.25%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)9.5%
EPS beat(12)7
Avg EPS beat(12)6.24%
EPS beat(16)11
Avg EPS beat(16)18.56%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-69.87%
PT rev (3m)-68.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.06%
EPS NY rev (1m)2.43%
EPS NY rev (3m)-14.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 17.81
Fwd PE 14.19
P/S 1.22
P/FCF 17.87
P/OCF 6.57
P/B 1.41
P/tB 1.68
EV/EBITDA 8.24
EPS(TTM)0.37
EY5.61%
EPS(NY)0.46
Fwd EY7.05%
FCF(TTM)0.37
FCFY5.6%
OCF(TTM)1
OCFY15.21%
SpS5.39
BVpS4.66
TBVpS3.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROCE 7.31%
ROIC 5.24%
ROICexc 5.64%
ROICexgc 6.28%
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
FCFM 6.85%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ROICexc(3y)14.67%
ROICexc(5y)11.45%
ROICexgc(3y)16.24%
ROICexgc(5y)12.7%
ROCE(3y)19.96%
ROCE(5y)15.59%
ROICexcg growth 3Y-15.7%
ROICexcg growth 5Y-1.81%
ROICexc growth 3Y-15.48%
ROICexc growth 5Y-2.08%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Debt/EBITDA 1.92
Cap/Depr 136.79%
Cap/Sales 11.76%
Interest Coverage 6.21
Cash Conversion 97.66%
Profit Quality 129.7%
Current Ratio 1.75
Quick Ratio 1.05
Altman-Z 2.44
F-Score5
WACC7.61%
ROIC/WACC0.69
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
EPS Next Y-1.04%
EPS Next 2Y10.53%
EPS Next 3Y11.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%
Revenue Next Year3.8%
Revenue Next 2Y4.5%
Revenue Next 3Y4.13%
Revenue Next 5YN/A
EBIT growth 1Y-7.97%
EBIT growth 3Y-13.49%
EBIT growth 5Y0.95%
EBIT Next Year68.18%
EBIT Next 3Y25.41%
EBIT Next 5YN/A
FCF growth 1Y-57.35%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-29.9%
OCF growth 3Y11.29%
OCF growth 5Y8.15%